发明名称 METHODS OF REDUCING LDL-P
摘要 In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing LDL-P comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.
申请公布号 US2015157593(A1) 申请公布日期 2015.06.11
申请号 US201314411835 申请日期 2013.06.28
申请人 Amarin Pharmaceuticals ireland Limited 发明人 Braeckman Rene;Soni Paresh;Stirtan William
分类号 A61K31/232;A61J1/03 主分类号 A61K31/232
代理机构 代理人
主权项 1. A method of reducing LDL-P in a subject in need thereof, comprising: determining a baseline LDL-P level associated with the subject; and thereafter administering to the subject about 1 g to about 4 g of ethyl eicosapentaenoate per day.
地址 Dublin IE